Book Description
Accompanied by supplements.
Author :
Publisher :
Page : 20 pages
File Size : 22,15 MB
Release : 1984
Category : Drugs
ISBN :
Accompanied by supplements.
Author :
Publisher :
Page : 16 pages
File Size : 20,38 MB
Release : 1980
Category : Drugs
ISBN :
Accompanied by supplements.
Author :
Publisher : DIANE Publishing
Page : 129 pages
File Size : 44,65 MB
Release : 2002
Category :
ISBN : 1428951938
Author : DIANE Publishing Company
Publisher : DIANE Publishing
Page : 740 pages
File Size : 14,33 MB
Release : 1995-09
Category : Medical
ISBN : 9780788104053
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Composed of 4 parts: approved prescription drug products with therapeutic equivalence evaluations; over-the-counter (OTC) drug products that require approved applications as a condition of marketing; drug products with approval under Sect. 505 of the Act; & products that have never been marketed, have been discontinued from marketing, or that have had their approvals withdrawn for other than safety or efficacy reasons.
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 483 pages
File Size : 33,47 MB
Release : 2017-09-28
Category : Medical
ISBN : 0309459575
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author :
Publisher :
Page : 256 pages
File Size : 50,83 MB
Release : 1980
Category : Drugs
ISBN :
Accompanied by supplements.
Author : Robin A. Cohen
Publisher :
Page : 12 pages
File Size : 45,26 MB
Release : 2015
Category : Drug utilization
ISBN :
Author : Eunjoo Pacifici
Publisher : Academic Press
Page : 292 pages
File Size : 40,30 MB
Release : 2018-06-13
Category : Medical
ISBN : 0128111569
Today's challenge, especially for many newcomers to the regulated industry, is not necessarily to gather regulatory information, but to know how to interpret and apply it. The ability to discern what is important from what is not, and to interpret regulatory documents correctly, provides a valuable competitive advantage to any newcomer or established professional in this field. An Overview of FDA Regulated Products: From Drugs and Medical Devices to Food and Tobacco provides a valuable summary of the key information to unveil the meaning of critical, and often complex, regulatory concepts. Concise and easy to read with practical explanations, key points, summaries and case studies, this book highlights the regulatory processes involved in bringing an FDA regulated product from research and development to approval and market. Although the primary focus will be on the US system, this book also features global perspectives where appropriate. A valuable resource for students, professors and professionals, An Overview of FDA Regulated Products illustrates the most important elements and concepts so that the reader can focus on the critical issues and make the necessary connections to be successful. - Provides an overview of key regulatory requirements using a practical approach that features detailed discussions of hypothetical and real-world case studies in order to highlight the concepts and applications of regulations - Covers all FDA regulated products, including drugs, biologics, medical devices, cosmetics, foods, dietary supplements, cosmetics, veterinary products, tobacco and more in one single reference - Illustrates complex topics in a clear, succinct and engaging manner by breaking down technical terms and offering straightforward and easy to understand explanations
Author :
Publisher :
Page : 1048 pages
File Size : 42,6 MB
Release : 2005
Category : Drugs
ISBN :
Author : Barry Leonard
Publisher : DIANE Publishing
Page : 829 pages
File Size : 17,21 MB
Release : 1999-04
Category :
ISBN : 0788173243
Identifies drug products approved on the basis of safety and effectiveness by the FDA under the Federal Food, Drug, and Cosmetic Act. Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation review) or pre-1938 drugs are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Contains therapeutic equivalence evaluations for approved multisource prescription drug products.